Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9822121 | 0.89 | RECQL (0.33) | RECQLALDH1A1HTT | |
| SCHEMBL9822243 | 0.83 | TP53 (0.33) | RECQLALDH1A1HTTKDM4E | |
| SCHEMBL9822300 | 0.82 | RECQL (0.37) | RECQLALDH1A1HTTPDE10AKDM4E | |
| SCHEMBL9300412 | 0.81 | RECQL (0.53) | RECQLALDH1A1HTTPDE10AKDM4E | |
| SCHEMBL9822398 | 0.78 | ALDH1A1 (0.34) | RECQLALDH1A1HTTKDM4E | |
| SCHEMBL9821985 | 0.76 | RECQL (0.37) | RECQLALDH1A1HTTPDE10A | |
| SCHEMBL9822069 | 0.76 | LMNA (0.35) | RECQLALDH1A1KDM4E | |
| SCHEMBL9143006 | 0.74 | ALDH1A1 (0.34) | ALDH1A1HTT | |
| SCHEMBL9142261 | 0.74 | POLB (0.33) | KDM4E | |
| SCHEMBL9140788 | 0.73 | DPP4 (0.40) | RECQLALDH1A1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4987129-A | BACTERICIDES | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4958019-A | Intermediates for synthesis of cephalosporin compounds | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4956462-A | Bactericides, ANTIBIOTICS, CEPHALOSPORINS | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-11 | — | — | US | disclosed |
| EP-0302633-A2 | Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same | SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) | 1989-02-08 | — | — | EP | disclosed |